NCT03468348View on ClinicalTrials.gov

Duloxetine for Acute Post-mastectomy Pain

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

February 10, 2020

Study Completion Date

February 10, 2020

Conditions
Acute Pain
Interventions
DRUG

Duloxetine

patients scheduled for mastectomy and axillary evacuation for cancer breast will receive orally, 2 hours before the operation either, placebo capsule, duloxetine 30 mg,duloxetine 60 mg or duloxetine 90 mg capsule.

Trial Locations (1)

71515

Diab, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03468348 - Duloxetine for Acute Post-mastectomy Pain | Biotech Hunter | Biotech Hunter